Generative AI in Personalized Medicine Market Report: Trends, Forecast and Competitive Analysis to 2030

Generative AI in Personalized Medicine Trends and Forecast

The future of generative AI in the global personalized medicine market looks promising with opportunities in the hospital and clinic, clinical research, healthcare organization, and diagnostic center markets. Generative AI in the global personalized medicine market is expected to grow with a CAGR of 39.5% from 2024 to 2030. The major drivers for this market are increasing prevalence of chronic diseases, growing inclination towards precision medicine, and rising demand for patient-centered care.

A more than 150-page report is developed to help in your business decisions.

Generative AI in Personalized Medicine by Segment

The study includes a forecast for generative AI in the global personalized medicine by deployment model, personalized medicine therapeutics, end use, and region.

Generative AI in Personalized Medicine Market by Deployment Model [Shipment Analysis by Value from 2018 to 2030]:

• On-Premise
• Cloud Based

Generative AI in Personalized Medicine Market by Personalized Medicine Therapeutics [Shipment Analysis by Value from 2018 to 2030]:

• Pharmaceutical
• Genomic Medicine

Generative AI in Personalized Medicine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals and Clinics
• Clinical Research
• Healthcare Organizations
• Diagnostic Centers

Generative AI in Personalized Medicine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Generative AI Companies in Personalized Medicine Market

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies generative AI companies in personalized medicine market cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the generative AI comapnies in personalized medicine market are profiled in this report include-

• Butterfly Network
• Deep Genomics
• Google
• IBM Watson Health
• Microsoft Corporation
• Aidoc
• Insilico Medicine
• PathAI
• Tencent Holdings
• Neuralink Corporation

Generative AI in Personalized Medicine Market Insights

Lucintel forecasts that cloud based is expected to witness the higher growth over the forecast period due to its flexibility, adaptability, accessibility, and cost-effectiveness.

Within this market, hospitals and clinics is expected to witness the highest growth due to the growing need for effective diagnosis and treatment planning.

North America will remain the largest region over the forecast period due to the existence of key players investing in AI, such as Microsoft, Apple, and Nvidia.

Features of the Generative AI in the Global Personalized Medicine Market

Market Size Estimates: Generative AI in personalized medicine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Generative AI in personalized medicine market size by deployment model, personalized medicine therapeutics, end use, and region in terms of value ($B).

Regional Analysis: Generative AI in personalized medicine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different deployment models, personalized medicine therapeutics, end uses, and regions for generative AI in the personalized medicine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of generative AI in the personalized medicine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for generative AI in personalized medicine market?

Answer: Generative AI in the global personalized medicine market is expected to grow with a CAGR of 39.5% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of generative AI in personalized medicine market?

Answer: The major drivers for this market are increasing prevalence of chronic diseases, growing inclination towards precision medicine, and rising demand for patient-centered care.

Q3. What are the major segments for generative AI in personalized medicine market?

Answer: The future of the generative AI in personalized medicine market looks promising with opportunities in the hospital and clinic, clinical research, healthcare organization, and diagnostic center markets.

Q4. Who are the key generative AI companies in personalized medicine market?

Answer: Some of the key generative AI companies in personalized medicine market are as follows:

• Butterfly Network
• Deep Genomics
• Google
• IBM Watson Health
• Microsoft Corporation
• Aidoc
• Insilico Medicine
• PathAI
• Tencent Holdings
• Neuralink Corporation

Q5. Which generative AI in personalized medicine market segment will be the largest in future?

Answer: Lucintel forecasts that cloud based is expected to witness the higher growth over the forecast period due to its flexibility, adaptability, accessibility, and cost-effectiveness.

Q6. In generative AI in personalized medicine market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to the existence of key players investing in AI, such as Microsoft, Apple, and Nvidia.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for generative AI in the personalized medicine market by deployment model (on-premise and cloud based), personalized medicine therapeutics (pharmaceutical and genomic medicine), end use (hospitals and clinics, clinical research, healthcare organizations, and diagnostic centers), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?